Come up with a name for your new list and we'll add to it:
NovelMed Therapeutics raised a round of funding on September 12, 2013. Investors include
National Institutes of Health.
NovelMed Therapeutics is a privately-held biotech company developing transformative treatments for orphan and non-orphan disease conditions. The company has developed a portfolio of antibodies targete…